IDEAYA Biosciences Inc (IDYA)
26.79
+0.19
(+0.71%)
USD |
NASDAQ |
Nov 22, 16:00
26.77
-0.02
(-0.07%)
After-Hours: 20:00
IDEAYA Biosciences Cash from Operations (Quarterly): -49.23M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -49.23M |
| June 30, 2024 | -32.88M |
| March 31, 2024 | -43.81M |
| December 31, 2023 | -23.75M |
| September 30, 2023 | -30.17M |
| June 30, 2023 | -33.46M |
| March 31, 2023 | -27.84M |
| December 31, 2022 | -23.37M |
| September 30, 2022 | -24.17M |
| June 30, 2022 | -19.99M |
| March 31, 2022 | -19.65M |
| December 31, 2021 | -16.66M |
| September 30, 2021 | -12.47M |
| June 30, 2021 | -12.93M |
| Date | Value |
|---|---|
| March 31, 2021 | -13.72M |
| December 31, 2020 | -11.60M |
| September 30, 2020 | 90.21M |
| June 30, 2020 | -13.61M |
| March 31, 2020 | -9.545M |
| December 31, 2019 | -8.706M |
| September 30, 2019 | -10.55M |
| June 30, 2019 | -10.27M |
| March 31, 2019 | -9.785M |
| December 31, 2018 | -7.477M |
| September 30, 2018 | -8.691M |
| June 30, 2018 | -5.926M |
| March 31, 2018 | -5.526M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-49.23M
Minimum
Sep 2024
90.21M
Maximum
Sep 2020
-16.87M
Average
-19.82M
Median
Cash from Operations (Quarterly) Benchmarks
| Gilead Sciences Inc | 4.309B |
| Vertex Pharmaceuticals Inc | 1.370B |
| Black Diamond Therapeutics Inc | -11.32M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -7.016M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -20.04M |
| Cash from Financing (Quarterly) | 286.50M |
| Free Cash Flow | -153.27M |
| Free Cash Flow Per Share (Quarterly) | -0.5765 |
| Free Cash Flow Yield | -7.51% |